Copper(I)/Triphenylphosphine Complexes Containing Naphthoquinone Ligands as Potential Anticancer Agents

Four new Cu/PPh3/naphtoquinone complexes were synthesized, characterized (IR, UV/visible, 1D/2D NMR, mass spectrometry, elemental analysis, and X-ray diffraction), and evaluated as anticancer agents. We also investigated the reactive oxygen species (ROS) generation capacity of complex 4, considering the well-established photochemical property of naphthoquinones. Therefore, employing the electron paramagnetic resonance (EPR) “spin trap”, 5,5-dimethyl-1-pyrroline N-oxide (DMPO) technique, we identified the formation of the characteristic •OOH species (hydroperoxyl radical) adduct even before irradiating the solution containing complex 4. As the irradiation progressed, this radical species gradually diminished, primarily giving rise to a novel species known as •DMPO-OH (DMPO + •OH radical). These findings strongly suggest that Cu(I)/PPh3/naphthoquinone complexes can generate ROS, even in the absence of irradiation, potentially intensifying their cytotoxic effect on tumor cells. Interpretation of the in vitro cytotoxicity data of the Cu(I) complexes considered their stability in cell culture medium. All of the complexes were cytotoxic to the lung (A549) and breast tumor cell lines (MDA-MB-231 and MCF-7). However, the higher toxicity for the lung (MRC5) and breast (MCF-10A) non-tumoral cells resulted in a low selectivity index. The morphological analysis of MDA-MB-231 cells treated with the complexes showed that they could cause decreased cell density, loss of cell morphology, and loss of cell adhesion, mainly with concentrations higher than the inhibitory concentration of 50% of cell viability (IC50) values. Similarly, the clonogenic survivance of these cells was affected only with concentrations higher than the IC50 values. An antimigratory effect was observed for complexes 1 and 4, showing around 20–40% of inhibition of wound closure in the wound healing experiments.

[1]  Chunyan Dong,et al.  Cu-related agents for cancer therapies , 2023, Coordination Chemistry Reviews.

[2]  Defeng Guan,et al.  Copper in cancer: From pathogenesis to therapy. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Z. Benfodda,et al.  An overview on the antibacterial properties of juglone, naphthazarin, plumbagin and lawsone derivatives and their metal complexes. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  B. Nowicka,et al.  Impact of cytotoxic plant naphthoquinones, juglone, plumbagin, lawsone and 2-methoxy-1,4-naphthoquinone, on Chlamydomonas reinhardtii reveals the biochemical mechanism of juglone toxicity by rapid depletion of plastoquinol. , 2023, Plant physiology and biochemistry : PPB.

[5]  P. Wang,et al.  Potential of Copper and Copper Compounds for Anticancer Applications , 2023, Pharmaceuticals.

[6]  J. Sessler,et al.  Cu(ii)-BODIPY photosensitizer for CAIX overexpressed cancer stem cell therapy , 2023, Chemical Science.

[7]  N. Raman,et al.  Transition metal complexes incorporating lawsone: a review , 2022 .

[8]  T. Gamberi,et al.  Metal-Based Complexes in Cancer Treatment , 2022, Biomedicines.

[9]  H. Heng,et al.  Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes , 2022, Medical Oncology.

[10]  Yanlin Jiang,et al.  Synthesis, Anti-tumour Activity, and Mechanism of Benzoyl hydrazine Schiff base-copper complexes , 2022, Journal of Molecular Structure.

[11]  H. Romanowicz,et al.  Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature) , 2022, Cancers.

[12]  G. Sala,et al.  Breast cancer in the era of integrating “Omics” approaches , 2022, Oncogenesis.

[13]  S. Balasubramanian,et al.  Early detection of cancer , 2022, Science.

[14]  M. Thomassen,et al.  Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review , 2022, Cancer and Metastasis Reviews.

[15]  Afnan Saleem,et al.  Chemokines in Triple-Negative Breast Cancer Heterogeneity: New Challenges for Clinical Implications. , 2022, Seminars in cancer biology.

[16]  S. Janciauskiene,et al.  Latest developments in metal complexes as anticancer agents , 2022, Coordination Chemistry Reviews.

[17]  G. Viale,et al.  Low-risk triple-negative breast cancers: clinico-pathological and molecular features. , 2022, Critical reviews in oncology/hematology.

[18]  Zhiyi Huo,et al.  Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes. , 2022, Nanomedicine.

[19]  Xiongwei Dong,et al.  Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment , 2021, Molecules.

[20]  M. Cominetti,et al.  Experimental and Theoretical DFT Study of Cu(I)/N,N-Disubstituted-N'-acylthioureato Anticancer Complexes: Actin Cytoskeleton and Induction of Death by Apoptosis in Triple-Negative Breast Tumor Cells. , 2021, Inorganic chemistry.

[21]  E. Garreffa,et al.  Breast cancer in the elderly, in men and during pregnancy , 2021, Surgery (Oxford).

[22]  R. Squitti,et al.  Copper in tumors and the use of copper-based compounds in cancer treatment. , 2021, Journal of inorganic biochemistry.

[23]  L. Ruiz-Azuara,et al.  Anti-proliferative, pro-apoptotic and anti-invasive effect of the copper coordination compound Cas III-La through the induction of reactive oxygen species and regulation of Wnt/β-catenin pathway in glioma , 2021, Journal of Cancer.

[24]  F. Bray,et al.  The ever‐increasing importance of cancer as a leading cause of premature death worldwide , 2021, Cancer.

[25]  J. Ranjitha,et al.  In vitro evaluations of biomolecular interactions, antioxidant and anticancer activities of Nickel(II) and Copper(II) complexes with 1:2 coordination of anthracenyl hydrazone ligands , 2021 .

[26]  Bernard Omondi,et al.  In vitro biological studies of heteroleptic Ag(I) and Cu(I) unsymmetrical N,N′-diarylformamidine dithiocarbamate phosphine complexes; the effect of the metal center , 2020 .

[27]  N. Singh,et al.  Anticancer potency of copper(II) complexes of thiosemicarbazones. , 2020, Journal of inorganic biochemistry.

[28]  M. Cominetti,et al.  Ru(ii)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer. , 2020, Dalton transactions.

[29]  M. Fares,et al.  Molecular principles of metastasis: a hallmark of cancer revisited , 2020, Signal Transduction and Targeted Therapy.

[30]  C. Ibiş,et al.  Reactions of quinones with some amino alcohols, thiols and a UV-Vis study , 2020 .

[31]  R. Hernández-Molina,et al.  Preparation of new metallic complexes from 2-hydroxy-3-((5-methylfuran-2-yl)methyl)-1,4-naphthoquinone , 2020 .

[32]  Nazzatush Shimar Jamaludin,et al.  Hirshfeld surface analysis of some new heteroleptic Copper(I) complexes , 2019, Journal of Molecular Structure.

[33]  Y. Qu,et al.  Two Cu(I) complexes constructed by different N-heterocyclic benzoxazole ligands: Syntheses, structures and fluorescent properties , 2019, Journal of Molecular Structure.

[34]  R. Franco,et al.  Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications , 2019, International journal of medical sciences.

[35]  M. Soriano-garcia,et al.  A New Family of Homoleptic Copper Complexes of Curcuminoids: Synthesis, Characterization and Biological Properties , 2019, Molecules.

[36]  C. Parthiban,et al.  Metal complexes of naphthoquinone based ligand: synthesis, characterization, protein binding, DNA binding/cleavage and cytotoxicity studies , 2018, Journal of biomolecular structure & dynamics.

[37]  U. Testa,et al.  Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells , 2018, Cancers.

[38]  L. Carvalho,et al.  Heterogeneity in Lung Cancer , 2018, Pathobiology.

[39]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[40]  E. Pereira,et al.  Metal complexes of hydroxynaphthoquinones: Lawsone, bis-lawsone, lapachol, plumbagin and juglone , 2017 .

[41]  M. Cominetti,et al.  Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis. , 2017, Journal of inorganic biochemistry.

[42]  Oscar A. Corona,et al.  Copper(I)-Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity. , 2017, Inorganic chemistry.

[43]  M. Soliman,et al.  Metal complexes in cancer therapy – an update from drug design perspective , 2017, Drug design, development and therapy.

[44]  R. Karvembu,et al.  Synthesis, characterization and catalytic oxidation property of copper(I) complexes containing monodentate acylthiourea ligands and triphenylphosphine , 2017 .

[45]  D. Zargarian,et al.  Estimating local bonding/antibonding character of canonical molecular orbitals from their energy derivatives. The case of coordinating lone pair orbitals , 2016 .

[46]  P. Vogt,et al.  In vitro wound healing assays – state of the art , 2016 .

[47]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[48]  A. Toro‐Labbé,et al.  Synthesis of new phosphorescent imidoyl-indazol and phosphine mixed ligand Cu(I) complexes – structural characterization and photophysical properties , 2016 .

[49]  Yuan Yuan,et al.  Synthesis, structure, terahertz spectroscopy and luminescent properties of copper (I) complexes with bis(diphenylphosphino)methane and N-donor ligands , 2015 .

[50]  D. Edward,et al.  A review of the efficacy of mitomycin C in glaucoma filtration surgery , 2015, Clinical ophthalmology.

[51]  S. Verma,et al.  Synthesis, electrochemical, fluorescence and antimicrobial studies of 2-chloro-3-amino-1,4-naphthoquinone bearing mononuclear transition metal dithiocarbamate complexes [M{κ2S,S-S2C–piperazine–C2H4N(H)ClNQ}n] , 2015 .

[52]  Kevin W. Wellington Understanding cancer and the anticancer activities of naphthoquinones – a review , 2015 .

[53]  Jennifer E Amon,et al.  An introduction to the wound healing assay using live-cell microscopy , 2014, Cell adhesion & migration.

[54]  J. Małecki,et al.  A copper(I) phosphine complex with 5,7-dinitro-2-methylquinolin-8-ol as co-ligand , 2014, Transition metal chemistry (Weinheim).

[55]  T. Sørensen,et al.  Synthesis, UV/vis spectra and electrochemical characterisation of arylthio and styryl substituted ferrocenes , 2011 .

[56]  N. Aliaga-Alcalde,et al.  Copper curcuminoids containing anthracene groups: fluorescent molecules with cytotoxic activity. , 2010, Inorganic chemistry.

[57]  Michal Zalibera,et al.  Thermal generation of stable spin trap adducts with super-hyperfine structure in their EPR spectra: An alternative EPR spin trapping assay for radical scavenging capacity determination in dimethylsulphoxide , 2009, Free radical research.

[58]  W. Kutner,et al.  In situ ESR spectroscopic evidence of the spin-trapped superoxide radical, O2−, electrochemically generated in DMSO at room temperature , 2008 .

[59]  Laura Gagliardi,et al.  Copper(I)-alpha-ketocarboxylate complexes: characterization and O2 reactions that yield copper-oxygen intermediates capable of hydroxylating arenes. , 2007, Journal of the American Chemical Society.

[60]  N. Miyata,et al.  DMPO-OH Radical Formation from 5,5-Dimethyl-1-pyrroline N-Oxide (DMPO) in Hot Water , 2007, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[61]  Suning Wang,et al.  Phosphorescent Cu(I) complexes of 2-(2'-pyridylbenzimidazolyl)benzene: impact of phosphine ancillary ligands on electronic and photophysical properties of the Cu(I) complexes. , 2006, Inorganic chemistry.

[62]  S. Bittner,et al.  Novel 2-amino-3-(2,4-dinitrophenylamino) derivatives of 1,4-naphthoquinone , 2005 .

[63]  N. Ferré,et al.  Assignment of the EPR spectrum of 5,5-dimethyl-1-pyrroline N-oxide (DMPO) superoxide spin adduct. , 2005, The Journal of organic chemistry.

[64]  G. Likhtenshtein,et al.  Synthesis and photochemical behavior of donor–acceptor systems obtained from chloro-1,4-naphthoquinone attached to trans-aminostilbenes , 2003 .

[65]  Pospíšil,et al.  Electron Transfer in Donor-Acceptor Molecules of Substituted Naphtoquinones: Spectral and Redox Properties of Internal Charge Transfer Complexes , 1996, Microchemical journal (Print).

[66]  F. H. Jardine,et al.  Copper(I) nitrato and nitrate complexes , 1971 .

[67]  K. A. Idriss,et al.  The visible absorbance maximum of 2-hydroxy-1,4-naphthoquinone as a novel probe for the hydrogen bond donor abilities of solvents and solvent mixtures , 1996 .